A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia

NCT02619604 | Completed

• 1 other identifier: Pro00063975
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).

Conditions

Chronic Lymphocytic Leukemia

Outcome Measures

Primary Outcomes (2)

• Change in provider knowledge with management of Quality of Life Concerns for CLL patients, as measured by survey

  Baseline, 6 months

• Change in provider confidence with management of Quality of Life Concerns for CLL patients, as measured by survey

  Baseline, 6 months

Study Arms (1)

Clinician education

OTHER

Other: Education Intervention

Interventions

Education Intervention OTHER

Education interventions will be delivered sporadically within the 6-month window between the time the clinician completes the pre-survey and when he/she completes the post-survey. Interventions consist of e-brief publications, teleconferences with project faculty, and evidence based resources.

Clinician education

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network
• Participant treats patients with CLL
• Participant is willing to participate in the educational component of this project
• Patient has a diagnosis of Chronic Lymphocytic Leukemia
• Patient is over the age of 18
• Patient is being treated at a Duke Cancer Network affiliate site,
• Patient is expected to see their physician or another member of their care team at least 3 times annually.
• Signed informed consent

You may not qualify if:

• None
• Patient is Non-English speaking
• Patient diagnosed with CLL \< 60 days ago

Sponsors & Collaborators

• Duke University: lead
• Med-IQ: collaborator
• Gilead Sciences: collaborator
• Genentech, Inc.: collaborator

Study Sites (1)

Duke Cancer Network

Durham, North Carolina, United States

Location

MeSH Terms

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

Early Intervention, Educational

Condition Hierarchy (Ancestors)

Leukemia, B-Cell; Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Child Health Services; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Preventive Health Services

Study Officials

• Linda Sutton, MD

  Duke University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 30, 2015
• First Posted: December 2, 2015
• Study Start: May 1, 2016
• Primary Completion: February 1, 2017
• Study Completion: February 1, 2017
• Last Updated: February 15, 2017

Record last verified: 2017-01

Locations

US (1)